Vitamin D-Dependent Rickets Type 1B (25-Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition? 2017

Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
CHU de Caen, Department of Genetics, Molecular Genetics Laboratory and Reference Center for Rare Diseases of Calcium and Phosphorus Metabolism, Caen, France.

Vitamin D requires a two-step activation by hydroxylation: The first step is catalyzed by hepatic 25-hydroxylase (CYP2R1, 11p15.2) and the second one is catalyzed by renal 1α-hydroxylase (CYP27B1, 12q13.1), which produces the active hormonal form of 1,25-(OH)2 D. Mutations of CYP2R1 have been associated with vitamin D-dependent rickets type 1B (VDDR1B), a very rare condition that has only been reported to affect 4 families to date. We describe 7 patients from 2 unrelated families who presented with homozygous loss-of-function mutations of CYP2R1. Heterozygous mutations were present in their normal parents. We identified a new c.124_138delinsCGG (p.Gly42_Leu46delinsArg) variation and the previously published c.296T>C (p.Leu99Pro) mutation. Functional in vitro studies confirmed loss-of-function enzymatic activity in both cases. We discuss the difficulties in establishing the correct diagnosis and the specific biochemical pattern, namely, very low 25-OH-D suggestive of classical vitamin D deficiency, in the face of normal/high concentrations of 1,25-(OH)2 D. Siblings exhibited the three stages of rickets based on biochemical and radiographic findings. Interestingly, adult patients were able to maintain normal mineral metabolism without vitamin D supplementation. One index case presented with a partial improvement with 1alfa-hydroxyvitamin D3 or alfacalcidol (1α-OH-D3 ) treatment, and we observed a dramatic increase in the 1,25-(OH)2 D serum concentration, which indicated the role of accessory 25-hydroxylase enzymes. Lastly, in patients who received calcifediol (25-OH-D3 ), we documented normal 24-hydroxylase activity (CYP24A1). For the first time, and according to the concept of personalized medicine, we demonstrate dramatic improvements in patients who were given 25-OH-D therapy (clinical symptoms, biochemical data, and bone densitometry). In conclusion, the current study further expands the CYP2R1 mutation spectrum. We note that VDDR1B could be easily mistaken for classical vitamin D deficiency. © 2017 American Society for Bone and Mineral Research.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003951 Diagnostic Errors Incorrect or incomplete diagnoses following clinical or technical diagnostic procedures. Diagnostic Blind Spots,Errors, Diagnostic,Misdiagnosis,Blind Spot, Diagnostic,Blind Spots, Diagnostic,Diagnostic Blind Spot,Diagnostic Error,Error, Diagnostic,Misdiagnoses
D004872 Ergocalciferols Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24. Calciferols,Vitamin D 2,Ergocalciferol,Vitamin D2,D2, Vitamin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072467 Cytochrome P450 Family 2 A cytochrome P450 enzyme family that includes members which function in the metabolism of STEROIDS; COUMARINS; and NICOTINE. CYP2 Enzymes,CYP2 Family
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
January 2004, Molecular genetics and metabolism,
Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
March 2024, JCEM case reports,
Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
December 1997, Molecular endocrinology (Baltimore, Md.),
Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
April 1974, The Gazette of the Egyptian Paediatric Association,
Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
August 2011, Journal of genetics,
Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
June 2021, Endocrine,
Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
October 1999, Molecular and cellular endocrinology,
Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
January 2018, Indian journal of dermatology,
Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
April 1980, The New England journal of medicine,
Arnaud Molin, and Arnaud Wiedemann, and Nick Demers, and Martin Kaufmann, and Jérémy Do Cao, and Laurent Mainard, and Brigitte Dousset, and Pierre Journeau, and Geneviève Abeguile, and Nadia Coudray, and Hervé Mittre, and Nicolas Richard, and Georges Weryha, and Arthur Sorlin, and Glenville Jones, and Marie-Laure Kottler, and Francois Feillet
April 1996, Indian pediatrics,
Copied contents to your clipboard!